Zantac Lawsuit is one of the leading lawsuits filed against Zantac due to its product, Zantac. Millions of Zantac cases will be filed throughout the next several years, claiming Zantac cause cancer. Zantac has settled suits for millions of dollars and will continue to do so. A good part of the Zantac Lawsuit process is the "burden of proof" process. In this case, the plaintiff needs to prove that there is or was a defect which caused their injury or illness. The burden of proof is what makes this type of lawsuit very different from other lawsuits.
As claimed by many Zantac Lawsuit plaintiffs, Zantac manufactures an ulcer pill that can only be taken with the prescription of a doctor. This ulcer pill can cause heartburn and other gastrointestinal problems. The reason why Zantac manufacturers placed an ulcer drug in their product is because they knew ulcer drug can cause gastrointestinal problems. According to Zantac Lawsuit plaintiffs, Zantac failed to warn its consumers about the risks of this ulcer pill which led to the victims filing lawsuits.
Zantac developed an ulcer drug that can help cure conditions such as ulcers, acid reflux, and heartburn. Zantac developed another ulcer drug called Flex Actrap which can also lead to cancer of the esophagus. The reason why Zantac developed these two drugs is that they are designed to treat the different symptoms of these illnesses while doing little to prevent recurring conditions.
Some of the Zantac Lawsuit plaintiffs were diagnosed with cancers of the throat, larynx, liver, esophagus, stomach, kidneys, gallbladder, pancreas, and more. Some Zantac Lawsuit plaintiffs were diagnosed with conditions that require them to undergo invasive surgery. Zantac developed a drug called Flex Actrap that can be used to perform endoscopic translucency, a procedure to correct lumps in the neck, ears, and other organs of the body which require endoscopic exploration. Zantac did not warn its consumers about the complications of this procedure since it does not involve invasive surgery. In the Zantac Lawsuit, the plaintiffs were diagnosed with carcinoma in situ (CIS) which is a type of cancer that develops in areas where collagen and elastin are produced.
The drug manufacturers Zantac Lawsuit developed Flex Actrap to correct the deficiencies of the transdermal delivery system for Flexpoint, a transdermal gel that is used to treat arthritis and rheumatoid arthritis. When the product was evaluated by the FDA, it was determined that the transdermal gel contains ingredients that can cause serious health complications. The FDA, according to the lawsuit, failed to warn Zantac that the transdermal gel could lead to such complications and that they should have taken measures to mitigate the risk of these complications.
The Zantac Lawsuit provides strong legal representation to one of the very sick children who experienced a negative drug reaction due to improper clinical trials conducted by the drug manufacturer. Although the lawsuits were filed against the drug manufacturer, their attorney also tried to blame the parents of the patient, claiming that they caused the child's condition through negligence. If you are faced with a similar situation and believe that the Food and Drug Administration or FDA made any errors in their analysis, you should consult an experienced lawyer who will review your case with the utmost dedication to get you the compensation you deserve. See more here...
Get more info at https://en.wikipedia.org/wiki/Ranitidine